Yuanxin Wang Selected Research

Sulfonamides

11/2020

Discovery of novel artemisinin-sulfonamidehybrids as potential carbonicanhydraseIX inhibitors with improved antiproliferative activities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuanxin Wang Research Topics

Disease

7	Neoplasms (Cancer) 05/2022 - 10/2019
2	Neoplasm Metastasis (Metastasis) 10/2019 - 01/2019
1	Ischemic Stroke 06/2021
1	Infarction (Infarctions) 06/2021
1	Cerebral Infarction 06/2021
1	cell-associated neurotoxicity 12/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2020
1	Fever (Fevers) 08/2020
1	Precocious Puberty 03/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Fibrosarcoma 11/2019
1	Melanoma (Melanoma, Malignant) 10/2019

Drug/Important Bio-Agent (IBA)

1	AntioxidantsIBA 05/2022
1	Biological ProductsIBA 05/2022
1	Polysaccharides (Glycans)IBA 05/2022
1	Sweetening Agents (Sweeteners)IBA 08/2021
1	Neuroprotective AgentsIBA 06/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2021
1	GinkgolidesIBA 06/2021
1	Protein Kinases (Protein Kinase)IBA 06/2021
1	SurvivinIBA 01/2021
1	ibrutinibIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 12/2020
1	artemisinin (artemisinine)IBA 11/2020
1	SulfonamidesIBA 11/2020
1	Complementary DNA (cDNA)IBA 08/2020
1	Vitamin D FDA LinkGeneric 03/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2019
1	paraform (paraformaldehyde)IBA 11/2019
1	Conditioned Culture MediaIBA 10/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019

Therapy/Procedure

1	Therapeutics 01/2021
1	Aftercare (After-Treatment) 11/2019
1	Immunotherapy 10/2019